Please login to the form below

Not currently logged in
Email:
Password:

Dr Stephen Hoffman joins Bicycle Therapeutics

He becomes chairman of the board

Cambridge, UK-headquartered Bicycle Therapeutics has named Dr Stephen Hoffman as chairman of its board of directors.

Dr Hoffman brings 30 years of experience in the pharmaceutical and financial industries to the biotech, currently serving as a senior advisor to PDL BioPharma and president of 10x Capital, an investment management firm.

He is also a member of the board of directors of AcelRx Pharmaceuticals, Dicerna Pharmaceuticals and Genocea Biosciences.

Previously, Dr Hoffman was managing director at Skyline Ventures from 2005 to 2014, and served as president, chairman, chief executive officer and director of Allos Therapeutics between 1994 and 2012.

Kevin Lee, chief executive of Bicycle Therapeutics, said: “Stephen has significant global healthcare experience and a strong track record of creating new medicines to address important unmet patient needs across a range of diseases, including oncology.

“We are pleased to welcome Stephen as our board chairman, and believe his experience founding, building and advising biotechnology companies will be instrumental in guiding the company as we develop innovative new cancer medicines and further advance our proprietary platform.” 

21st July 2016

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics